Tuberculosis & HIV Co-Infection Training Program in Kenya
Tuberculosis & HIV Co-Infection Training Program in Kenya
批准号:
10239543
负责人:
Thomas R Hawn
金额:
$29.11万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2021
资助国家:
美国
项目状态:
未结题
起止时间:
2021-05-01 至 2026-03-31
关键词:
AddressBacillusBiometryCause of DeathChildhoodCollaborationsCountryCoupledEducational workshopEpidemicEpidemiologyFellowshipGoalsHIVHIV InfectionsHIV/TBHealthInfection preventionKenyaLaboratoriesLeprosyLung diseasesMedical ResearchMentorsMycobacterium tuberculosisPediatric ResearchPharmaceutical PreparationsPharmacotherapyPublic HealthRecording of previous eventsResearchResearch InstituteResearch PersonnelResearch Project GrantsScientistTrainingTraining ProgramsTreatment ProtocolsTuberculosisUniversitiesVaccinesWashingtonWorkco-infectioncombatdoctoral studentinterestmacrophagenext generationnovelprogramssupportive environmenttraining opportunity
中文摘要
摘要
结核病(TB)是艾滋病毒感染者(PLHIV)的主要死亡原因。尽管
100多年前结核分枝杆菌(Mtb)的发现和有效药物的可获得性
60多年来,控制结核病仍然存在着巨大的障碍,包括缺乏高效的
疫苗,长期药物治疗方案,预防感染,杀死巨噬细胞内的休眠细菌。
为了解决这些问题,需要开发新的研究和公共卫生战略,并将其结合起来
在结核病高发国家加强培训和当地能力建设。肯尼亚是30个结核病高发区之一
造成负担的国家加起来占全球结核病病例的80%以上。内罗毕大学(UON),
肯尼亚医学研究所(KEMRI)和华盛顿大学(UW)提出了一项新的
结核病-艾滋病毒培训计划(TBHTP)以满足这些需求。TBHTP包括在以下方面的密切合作
肯尼亚与卫生部国家结核病、麻风和肺病项目(MoH NTLP)合作,以及
肯尼亚儿科研究联盟(KEPRECON)-附属于肯尼亚的研究组织
儿科协会(KPA)我们计划的主要目标是协作开发培训
在培训和研究能力建设方面满足当地需求的机会。这一伙伴关系建立在35-
威斯康星大学、KEMRI和UON在艾滋病毒研究方面合作和培训的一年历史。虽然这件事
尽管伙伴关系取得了很大成功,但结核病并不是以前努力的高度优先事项或重点目标。至
建设KEMRI和内罗毕大学(UON)进行结核病和结核病-艾滋病毒联合感染的能力
调研后,我们建议实行学位制的长期培训轨道,实行中期不培训
学位赛道和短期训练赛道。在5年内,我们将培训5 UW英里每小时,5 UON
流行病学奖学金,以及在KEMRI、UON或卫生部工作的5名UON博士生。我们还将进行培训
10名对结核病研究有兴趣和潜力的中期非学位科学家将参加威斯康星大学的
学习流行病学和生物统计学的课程,或在实验室工作一到三个月,然后回到
并参与了一个有指导的研究项目。最后,我们将举办短期研讨会,并提供
建立大量训练有素的研究人员的在线课程,这些研究人员将为
结核病方面的研究。这些培训机会加在一起,将提高当地的能力,并培训下一个
将发现抗击结核病的新研究和公共卫生战略的一代领导人
肯尼亚的流行病。
英文摘要
Abstract
Tuberculosis (TB) is the leading cause of death in people living with HIV infection (PLHIV). Despite the
discovery of Mycobacterium tuberculosis (Mtb) over 100 years ago and the availability of effective drugs for
over 60 years, there remain formidable hurdles for controlling TB including the lack of a highly efficacious
vaccine, long drug treatment regimens, prevention of infection, and killing dormant bacilli within macrophages.
To address these problems, novel research and public health strategies need to be developed and coupled
with enhanced training and local capacity building in high TB endemic countries. Kenya is one of 30 TB high
burden countries which together constitute over 80% of global TB cases. The University of Nairobi (UoN),
the Kenya Medical Research Institute (KEMRI) and the University of Washington (UW) propose a new
TB-HIV Training Program (TBHTP) to address these needs. The TBHTP includes close partnerships in
Kenya with the Ministry of Health National Tuberculosis Leprosy and Lung Disease Program (MoH NTLP), and
the Kenya Pediatric Research Consortium (KEPRECON) – the research organization affiliated with the Kenya
Pediatric Association (KPA). The primary goal of our program is to collaboratively develop training
opportunities to address local needs in training and research capacity building. This partnership builds on a 35-
year history of collaboration and training in HIV research between UW, KEMRI, and UoN. Although this
partnership has been highly successful, TB has not been a high priority or focused goal of previous efforts. To
build the capacity of KEMRI and the University of Nairobi (UoN) to conduct TB and TB-HIV co-infection
research, we propose to implement a long-term training degree-earning track, a medium-term training non-
degree track, and a short-term training track. During the 5-year period, we will train 5 UW MPH, 5 UoN
Fellowship in Epidemiology, and 5 UoN PhD students working at KEMRI, UoN, or the MoH. We will also train
10 medium term non-degree scientists who have interest and potential in TB research will attend UW and take
coursework in epidemiology and biostatistics or work in a laboratory for one to three months before returning to
Kenya and engaging in a mentored research project. Finally, we will conduct short term workshops and provide
on-line courses to build a critical mass of trained researchers who will create a supportive environment for
research in TB. Together, these training opportunities will enhance local capacity and train the next
generation of leaders who will discover novel research and public health strategies to combat the TB
epidemic in Kenya.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Development Core
-
批准号:10425947
-
项目类别:
-
资助金额:$22.37万
-
财政年份:2022
-
负责人:Thomas R Hawn
-
依托单位:
Development Core
-
批准号:10595068
-
项目类别:
-
资助金额:$41.92万
-
财政年份:2022
-
负责人:Thomas R Hawn
-
依托单位:
Administrative Core
-
批准号:10653901
-
项目类别:
-
资助金额:$18.2万
-
财政年份:2021
-
负责人:Thomas R Hawn
-
依托单位:
Administrative Core
-
批准号:10271169
-
项目类别:
-
资助金额:$15.09万
-
财政年份:2021
-
负责人:Thomas R Hawn
-
依托单位:
Tuberculosis & HIV Co-Infection Training Program in Kenya
-
批准号:10596477
-
项目类别:
-
资助金额:$28.69万
-
财政年份:2021
-
负责人:Thomas R Hawn
-
依托单位:
Human macrophage variation & TB pathogenesis
-
批准号:10459540
-
项目类别:
-
资助金额:$49.95万
-
财政年份:2021
-
负责人:Thomas R Hawn
-
依托单位:
Tuberculosis & HIV Co-Infection Training Program in Kenya
-
批准号:10392506
-
项目类别:
-
资助金额:$28.71万
-
财政年份:2021
-
负责人:Thomas R Hawn
-
依托单位:
Administrative Core
-
批准号:10459535
-
项目类别:
-
资助金额:$14.69万
-
财政年份:2021
-
负责人:Thomas R Hawn
-
依托单位:
Human macrophage variation & TB pathogenesis
-
批准号:10271173
-
项目类别:
-
资助金额:$49.27万
-
财政年份:2021
-
负责人:Thomas R Hawn
-
依托单位:
Human macrophage variation & TB pathogenesis
-
批准号:10653916
-
项目类别:
-
资助金额:$44.99万
-
财政年份:2021
-
负责人:Thomas R Hawn
-
依托单位:
Aerobiology, immunology, and Mycobacterium tuberculosis transmission
-
批准号:10427333
-
项目类别:
-
资助金额:$73.39万
-
财政年份:2020
-
负责人:Thomas R Hawn
-
依托单位:
Aerobiology, immunology, and Mycobacterium tuberculosis transmission
-
批准号:10214456
-
项目类别:
-
资助金额:$69.36万
-
财政年份:2020
-
负责人:Thomas R Hawn
-
依托单位:
Aerobiology, immunology, and Mycobacterium tuberculosis transmission
-
批准号:10669026
-
项目类别:
-
资助金额:$74.74万
-
财政年份:2020
-
负责人:Thomas R Hawn
-
依托单位:
Pulmonary Innate Immunity & Resistance to Mycobacterium Tuberculosis Infection
-
批准号:10328504
-
项目类别:
-
资助金额:$17.63万
-
财政年份:2018
-
负责人:Thomas R Hawn
-
依托单位:
CD180 and the Macrophage Response to Legionella pneumophila
-
批准号:8303867
-
项目类别:
-
资助金额:$23.15万
-
财政年份:2012
-
负责人:Thomas R Hawn
-
依托单位:
CD180 and the Macrophage Response to Legionella pneumophila
-
批准号:8442826
-
项目类别:
-
资助金额:$19.31万
-
财政年份:2012
-
负责人:Thomas R Hawn
-
依托单位:
Innate Immunogenetics & Human Infections
-
批准号:8690745
-
项目类别:
-
资助金额:$14.84万
-
财政年份:2010
-
负责人:Thomas R Hawn
-
依托单位:
Innate Immunogenetics & Human Infections
-
批准号:8110589
-
项目类别:
-
资助金额:$15.03万
-
财政年份:2010
-
负责人:Thomas R Hawn
-
依托单位:
Innate Immunogenetics & Human Infections
-
批准号:8287616
-
项目类别:
-
资助金额:$14.97万
-
财政年份:2010
-
负责人:Thomas R Hawn
-
依托单位:
Innate Immunogenetics & Human Infections
-
批准号:7952456
-
项目类别:
-
资助金额:$14.75万
-
财政年份:2010
-
负责人:Thomas R Hawn
-
依托单位:
国内基金
海外基金
登录
查看更多内容
前列腺驻留菌Bacillus cereus促进前列腺增生的作用机制研究
-
批准号:2026JJ81651
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:谢宇
-
依托单位:
猪源益生菌Bacillus licheniformis PGM584缓解仔猪断奶腹泻的机制研究
-
批准号:2025JJ50141
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:王启业
-
依托单位:
基于Bacillus subtilis 细胞传感器介导的肠道环境中结直肠癌相关生物标志物的动态检测策略
-
批准号:82372355
-
项目类别:面上项目
-
资助金额:48万元
-
批准年份:2023
-
负责人:王永忠
-
依托单位:
枯草芽孢杆菌Bacillus subtilis T5高效制备纳米硒及其合成机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:
-
依托单位:
生物炭载解化感物质促生菌Bacillus cereus WL08缓解半夏连作障碍的机制研究
-
批准号:32360023
-
项目类别:地区科学基金项目
-
资助金额:32万元
-
批准年份:2023
-
负责人:张承
-
依托单位:
工程化Bacillus clausii胞外囊泡口服递送PD-L1自阻断质粒协同抗胰腺癌作用研究
-
批准号:82373277
-
项目类别:面上项目
-
资助金额:49万元
-
批准年份:2023
-
负责人:刘克海
-
依托单位:
CRISPR/CasΦ介导的Bacillus subtilis基因组精简重排进化与生理机制解析
-
批准号:32300064
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2023
-
负责人:武耀康
-
依托单位:
芽孢杆菌Bacillus sp.E044对羊肚菌主要病害-镰刀菌病生物防治的作用机制
-
批准号:22ZR1442500
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2022
-
负责人:吕贝贝
-
依托单位:
Bacillus sp. DT2与凤眼莲根际生物膜对四环素的协同降解机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:54万元
-
批准年份:2022
-
负责人:卢信
-
依托单位:
基于Bacillus safensis的聚乳酸降解酶催化机制解析与分子改造
-
批准号:--
-
项目类别:面上项目
-
资助金额:54万元
-
批准年份:2022
-
负责人:王战勇
-
依托单位: